Characteristics of surviving and nonsurviving patients with primary pulmonary hypertensionRICH, S; LEVY, P. S.The American journal of medicine. 1984, Vol 76, Num 4, pp 573-578, issn 0002-9343Article

Actualité de l'artériopathie pulmonaire plexogénique de cause inconnue = Actuality of plexogenic pulmonary arteriopathy of unknown originLOCHART, A.Clinical respiratory physiology. 1983, Vol 19, Num 5, pp 521-530, issn 0272-7587Article

Primary pulmonary hypertension: current updateRICH, S; BRUNDAGE, B. H.JAMA, the journal of the American Medical Association. 1984, Vol 251, Num 17, pp 2252-2254, issn 0098-7484Article

Unexplained severe pulmonary hypertension in the older age groupPHIPPS, B; WONG, B; CHANG, C. H. J et al.Chest. 1983, Vol 84, Num 4, pp 399-402, issn 0012-3692Article

Severe pulmonary artery hypertensionROGLAN, A; ARTIGAS, A; SOLE, J et al.Intensive care medicine (Print). 1988, Vol 14, Num 5, pp 510-518, issn 0342-4642Article

Action de l'oxygénothérapie (O.T.) sur l'hypertension artérielle pulmonaire chronique (H.T.A.P.C.) = The action of oxygen therapy (O.T.) on chronic pulmonary artery hypertension (C. P. A. H. T.)MUIR, J. F; DEFUOUILLOY, C; LEVI-VALENSI, P et al.Revue de pneumologie clinique (Paris). 1984, Vol 40, Num 3, pp 179-190, issn 0761-8417Article

Comparative effects of isosorbide dinitrate, prednisolone, indomethacin, and elastase on the development of monocrotaline-induced pulmonary hypertensionKATO, T; KITAMURA, H; KANISAWA, M et al.Experimental and molecular pathology. 1989, Vol 50, Num 3, pp 305-315, issn 0014-4800, 11 p.Article

Pulmonary hypertension in pediatric patientsPERKIN, R. M; ANAS, N. G.The Journal of pediatrics. 1984, Vol 105, Num 4, pp 511-522, issn 0022-3476Article

Sarcoidosis and reactive pulmonary hypertensionBARST, R. J; RATNER, S. J.Archives of internal medicine (1960). 1985, Vol 145, Num 11, pp 2112-2114, issn 0003-9926Article

Proceedings of national heart, lung, and blood institute pediatric cardiology workshop: pulmonary hypertensionFRIEDMAN, W. F.Pediatric research. 1986, Vol 20, Num 9, pp 811-824, issn 0031-3998Article

Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertensionYEAGER, Michael E; COLVIN, Kelley L; EVERETT, Allen D et al.Proteomics. Clinical applications (Print). 2012, Vol 6, Num 5-6, pp 257-267, issn 1862-8346, 11 p.Article

Chronic thromboembolic pulmonary hypertensionFEDULLO, Peter F; AUGER, William R; KERR, Kim M et al.Seminars in respiratory and critical care medicine. 2003, Vol 24, Num 3, pp 273-285, issn 1069-3424, 13 p.Article

Pulmonary hypertension in the collagen vascular diseasesTANOUE, Lynn T.Seminars in respiratory and critical care medicine. 2003, Vol 24, Num 3, pp 287-295, issn 1069-3424, 9 p.Article

Transient effect of nifedipine on pulmonary hypertension of systemic sclerosisFUDMAN, E. J; KELLING, D. G. JR.Journal of rheumatology. 1985, Vol 12, Num 6, pp 1191-1192, issn 0315-162XArticle

Pulmonary arterial hypertension and emphysemaWILLIAMS, I. P; BOYD, M. J; HUMBERSTONE, A. M et al.British journal of diseases of the chest. 1984, Vol 78, Num 3, pp 211-216, issn 0007-0971Article

Pulmonary hypertension associated with abnormal hemoglobinHALES, C. A; MARK, E. J.The New England journal of medicine. 1983, Vol 309, Num 26, pp 1627-1636, issn 0028-4793Article

The acute administration of vasodilators in primary pulmonary hypertension: Experience from the national institutes of health registry on primary pulmonary hypertensionWEIR, E. K; RUBIN, L. J; KERNIS, J. T et al.The American review of respiratory disease. 1989, Vol 140, Num 6, pp 1623-1630, issn 0003-0805Article

Prevention and reversal of hypoxic pulmonary hypertension by calcium antagonistsSTANBROOK, H. S; MORRIS, K. G; MCMURTRY, I. F et al.The American review of respiratory disease. 1984, Vol 130, Num 1, pp 81-85, issn 0003-0805Article

Vasodilator therapy for primary pulmonary hypertensionMCGOON, M. D; VLIETSTRA, R. E.Mayo Clinic proceedings. 1984, Vol 59, Num 10, pp 672-677, issn 0025-6196Article

Heme oxygenase is expressed in human pulmonary artery smooth muscle where carbon monoxide has an anti-proliferative roleSTANFORD, Salome J; WALTERS, Matthew J; HISLOP, Alison A et al.European journal of pharmacology. 2003, Vol 473, Num 2-3, pp 135-141, issn 0014-2999, 7 p.Article

Amrinone versus conventional therapy in pulmonary hypertensive patients awaiting cardiac transplantationDEEB, G. M; BOLLING, S. F; GUYNN, T. P et al.The Annals of thoracic surgery. 1989, Vol 48, Num 5, pp 665-669, issn 0003-4975, 5 p.Article

Conference report/ Pulmonary vascular reactivity, Deckers, CO, October 10-12, 1984REEVES, J. T; GROVER, R. F; MCMURTRY, I et al.Clinical respiratory physiology. 1985, Vol 21, Num 6, pp 583-590, issn 0272-7587Conference Proceedings

Evolution of pulmonary hypertension in chronic respiratory diseasesWEITZENBLUM, E; JEZEK, V.Clinical respiratory physiology. 1984, Vol 20, Num 1, pp 73-81, issn 0272-7587Article

Hypertension artérielle pulmonaire primitive: effets des vasodilatateurs à propos d'une observation avec biopsie pulmonaire = Primary pulmonary arterial hypertension. Effects of vasodilators based on a care reportLEMOIGNE, F; BONNAUD, F; CLARY, C et al.Revue des maladies respiratoires. 1984, Vol 1, Num 6, pp 337-342, issn 0761-8425Article

Peripartum heart failure due to primary pulmonary hypertensionNELSON, D. M; MAIN, E; CRAFFORD, W et al.Obstetrics and gynecology (New York. 1953). 1983, Vol 62, Num 3, pp 58S-63S, issn 0029-7844Article